Is bexsero the same as Trumenba?
Though the two vaccines are similar, they are not interchangeable. Bexsero is a GlaxoSmithKline (GSK) brand while Trumenba is made by Pfizer. Bexsero follows a two-dose schedule with one 0.5 ml dose followed by a second 0.5 ml dose administered one month later.
Can you interchange bexsero and Trumenba?
You can administer either two doses of Bexsero (MenB-4C) 4 weeks apart, or three doses of Trumenba (MenB-FHbp) on a 0-, 1–2-, and 6-month schedule.
What is the difference between the two meningitis vaccines?
The MenACWY vaccine is very effective at protecting against four strains of the bacteria, while the MenB vaccine protects against a fifth strain.
What type of vaccines are serogroup B meningococcal vaccines bexsero and Trumenba )?
There are 2 types of meningococcal vaccines available in the United States: Meningococcal conjugate or MenACWY vaccines (Menactra®, Menveo®, and MenQuadfi®) Serogroup B meningococcal or MenB vaccines (Bexsero®and Trumenba®)
What is bexsero vaccine?
BEXSERO is a vaccine indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B. BEXSERO is approved for use in individuals aged 10 through 25 years.
What type of vaccines are serogroup B meningococcal vaccines?
Serogroup B meningococcal (MenB) vaccines can help prevent meningococcal disease caused by serogroup B. Other meningococcal vaccines are recommended to help protect against serogroups A, C, W, and Y.
Is Trumenba an OMV?
Also, a third group B vaccine based on two recombinant factor H binding proteins (Trumenba®, Pfizer), has recently been licenced but it does not include OMV. This commentary explores the population impact that group B OMV vaccines have had on meningococcal and gonorrhoea diseases.
Is Trumenba a meningococcal vaccine?
The FDA is announcing the approval of Trumenba, the first vaccine approved in the United States to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroup B in individuals 10 through 25 years of age. Trumenba is manufactured by Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.
Is bexsero OMV or recombinant?
Currently there are two OMV-containing group B vaccines available, the new recombinant protein-based Bexsero® developed by Novartis and VA-MENGOC-BC® developed by the Finlay institute in Cuba.
